---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-006850"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2024-10-02T23:59:59+00:00"
generated_at: "2026-05-30T22:54:40.086243+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical shareholders approve 3M share increase to 2020 Equity Plan; all director nominees elected

## Summary
- Shareholders approved amendment to 2020 Equity Incentive Plan, increasing authorized shares by 3,000,000 to total 3,364,256 shares.
- Five directors elected: Broenniman, Frakes, Gikakis, Rossetti, Shah, each with over 2.9M votes for.
- Ratification of Haskell & White LLP as independent auditor approved: 4.70M for, 163,731 against.
- Non-binding advisory vote on executive compensation approved: 2.76M for, 245,575 against.
- Plan amendment effective September 27, 2024, after receiving stockholder approval.

## SEC filing metadata
- accession: 0001683168-24-006850
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2024-10-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316824006850/0001683168-24-006850-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316824006850/aethlon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-006850
- JSON: https://secwatch.observer/filing/0001683168-24-006850.json
- Plain text: https://secwatch.observer/filing/0001683168-24-006850.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.